Getinge (OTCMKTS:GNGBY) Reaches New 1-Year High – Here’s Why

Getinge (OTCMKTS:GNGBY)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as $25.24 and last traded at $25.24, with a volume of 402 shares traded. The stock had previously closed at $25.1550.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Getinge from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Strong Buy”.

Getinge Stock Performance

The company has a debt-to-equity ratio of 0.26, a current ratio of 1.31 and a quick ratio of 0.74. The company has a market cap of $6.87 billion, a price-to-earnings ratio of 24.04 and a beta of 0.92. The firm has a 50 day simple moving average of $22.39 and a 200-day simple moving average of $21.46.

Getinge (OTCMKTS:GNGBY) last announced its quarterly earnings results on Friday, July 17th. The company reported $0.38 EPS for the quarter. The business had revenue of $894.87 million for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%. As a group, analysts predict that Getinge will post 1.38 EPS for the current fiscal year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.